133 related articles for article (PubMed ID: 12395897)
1. Elevated (> or = 10%) MIB-1 proliferative index correlates with poor outcome in gastric stromal tumor patients: a study of 35 cases.
Toquet C; Le Néel JC; Guillou L; Renaudin K; Hamy A; Heymann MF; Simon-Valla S; Le Borgne J; Maugard C; Fiche M
Dig Dis Sci; 2002 Oct; 47(10):2247-53. PubMed ID: 12395897
[TBL] [Abstract][Full Text] [Related]
2. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens.
Ma CK; De Peralta MN; Amin MB; Linden MD; Dekovich AA; Kubus JJ; Zarbo RJ
Am J Clin Pathol; 1997 Dec; 108(6):641-51. PubMed ID: 9384445
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients.
Fujimoto Y; Nakanishi Y; Yoshimura K; Shimoda T
Gastric Cancer; 2003; 6(1):39-48. PubMed ID: 12673425
[TBL] [Abstract][Full Text] [Related]
4. The relationship between MIB-1 proliferative activity and mitotic index in gastrointestinal stromal tumors.
Filiz G; Yalçinkaya O; Gürel S; Yerci O; Memik F
Hepatogastroenterology; 2007 Mar; 54(74):438-41. PubMed ID: 17523292
[TBL] [Abstract][Full Text] [Related]
5. Surgery of upper GI gastrointestinal stromal tumors: our experience, prognostic analysis.
Kasetsermwiriya W; Nagai E; Nakata K; Nagayoshi Y; Shimizu S; Tanaka M
Hepatogastroenterology; 2015; 62(137):87-92. PubMed ID: 25911874
[TBL] [Abstract][Full Text] [Related]
6. Comparing the long-term outcomes among patients with stomach and small intestine gastrointestinal stromal tumors: An analysis of the National Cancer Database.
Giuliano K; Ejaz A; Reames BN; Choi W; Sham J; Gage M; Johnston FM; Ahuja N
J Surg Oncol; 2018 Sep; 118(3):486-492. PubMed ID: 30129672
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in malignant gastrointestinal stromal tumors.
Muro-Cacho CA; Cantor AB; Morgan M
Ann Clin Lab Sci; 2000 Jul; 30(3):239-47. PubMed ID: 10945563
[TBL] [Abstract][Full Text] [Related]
8. Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach.
Wong NA; Young R; Malcomson RD; Nayar AG; Jamieson LA; Save VE; Carey FA; Brewster DH; Han C; Al-Nafussi A
Histopathology; 2003 Aug; 43(2):118-26. PubMed ID: 12877726
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of malignancy using Ki-67 labeling index for gastric stromal tumor.
Nagasako Y; Misawa K; Kohashi S; Hasegawa K; Okawa Y; Sano H; Takada A; Sato H
Gastric Cancer; 2003; 6(3):168-72. PubMed ID: 14520530
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
11. [The value of (18)F-FDG PET-CT imaging in predicting the malignant potential of GIST].
Li SX; Tang MD; Lin DY; Liu DJ; Lyu QH; Zhang JP; Cai ZH
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):821-827. PubMed ID: 29151288
[No Abstract] [Full Text] [Related]
12. P53 and MIB-1 expression in gastrointestinal stromal tumor (GIST) of the stomach.
Hata Y; Ishigami S; Natsugoe S; Nakajo A; Okumura H; Miyazono F; Matsumoto M; Hokita S; Aikou T
Hepatogastroenterology; 2006; 53(70):613-5. PubMed ID: 16995473
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumor: a study of 156 cases].
Liang YM; Li XH; Lü YY; Lü YL; Zhong M; Pu XL; Li WM
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):233-8. PubMed ID: 17706113
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic role of molecular markers in 99 KIT-positive gastric stromal tumors in Taiwanese.
Hu TH; Chuah SK; Lin JW; Chiu YC; Changchien CS; Wang CC; Chen YS; Yi LN; Chiu KW; Lee CM
World J Gastroenterol; 2006 Jan; 12(4):595-602. PubMed ID: 16489674
[TBL] [Abstract][Full Text] [Related]
15. Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index.
Lee HE; Mounajjed T; Erickson LA; Wu TT
Endocr Pathol; 2016 Sep; 27(3):259-67. PubMed ID: 27306997
[TBL] [Abstract][Full Text] [Related]
16. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
17. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer.
Thor AD; Liu S; Moore DH; Edgerton SM
J Clin Oncol; 1999 Feb; 17(2):470-7. PubMed ID: 10080587
[TBL] [Abstract][Full Text] [Related]
19. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis.
Guller U; Tarantino I; Cerny T; Ulrich A; Schmied BM; Warschkow R
Gastric Cancer; 2017 Jan; 20(1):49-60. PubMed ID: 26649434
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors.
Carrillo R; Candia A; Rodriguez-Peralto JL; Caz V
Hum Pathol; 1997 Feb; 28(2):160-5. PubMed ID: 9023396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
